← Co-Diagnostics (CODX)

Co-Diagnostics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 8-KNov. 20, 2026, 4:30 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits

  • 8-KNov. 19, 2026, 5:10 p.m. ETView on SEC.govOur explainer

    Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCo-Diagnostics announces 1-for-25 reverse stock split effective November 24, 2026, to support Nasdaq $1.00 minimum bid compliance

  • 8-KNov. 13, 2026, 5 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Submission of matters to a vote of security holders · Financial statements and exhibits

    AI summary, unreviewedCo-Diagnostics Shareholders Approve Plan Share Increase, Reverse Split Authority of Up to 1-for-750 and Warrant Issuance at Special Meeting

  • 8-KNov. 10, 2026, 8:02 a.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCo-Diagnostics Q3 2026 Net Loss Narrows to $1.01 Per Share vs $1.25 Consensus; Revenue Rises to $0.3 Million, Cash Falls to $0.7 Million

  • 8-KOct. 15, 2026, 4:15 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

  • 8-KOct. 13, 2026, 6:10 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Financial statements and exhibits

  • 8-KOct. 2, 2026, 7:38 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

    AI summary, unreviewedCo-Diagnostics Annual Meeting Fails Quorum Again, Adjourned to October 14, 2026

  • 8-KSept. 25, 2026, 4:45 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

  • 8-KSept. 16, 2026, 10:30 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 8-KSept. 16, 2026, 8:45 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 8-KSept. 15, 2026, 4:05 p.m. ETView on SEC.gov

    Other events

  • 8-KSept. 4, 2026, 4:30 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

  • 8-KSept. 4, 2026, 9 a.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

  • 8-KAug. 13, 2026, 4:03 p.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

  • 8-KJuly 31, 2026, 8:30 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Financial statements and exhibits

  • 8-KJuly 27, 2026, 5:05 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Financial statements and exhibits